New Medicare Coverage Policy for Next-Generation Tumor Sequencing: A Key Shift in Coverage Criteria With Broad Implications Beyond Medicare
JCO Precis Oncol
.
2018;2:PO.18.00206.
doi: 10.1200/PO.18.00206.
Epub 2018 Nov 8.
Authors
K A Phillips
1
2
3
4
,
J R Trosman
1
2
5
,
C B Weldon
2
5
,
M P Douglas
1
2
Affiliations
1
University of California at San Francisco, Department of Clinical Pharmacy.
2
Center for Translational and Policy Research on Personalized Medicine (TRANSPERS).
3
UCSF Philip R. Lee Institute for Health Policy.
4
UCSF Helen Diller Family Comprehensive Cancer Center.
5
Center for Business Models in Healthcare.
PMID:
31073549
PMCID:
PMC6503521
DOI:
10.1200/PO.18.00206
No abstract available
Publication types
Comment
Grant support
P30 CA082103/CA/NCI NIH HHS/United States
R01 CA221870/CA/NCI NIH HHS/United States
R01 HG007063/HG/NHGRI NIH HHS/United States
U01 HG009599/HG/NHGRI NIH HHS/United States